Moleculin spotlights completed Part A enrollment in MIRACLE trial, with full 90-patient readout targeted for Q1 2027
Market Chameleon (Wed, 21-Oct 11:22 AM)
MBRX Jumps After CEO Corner Highlights MIRACLE Trial Enrollment Completion and a Q1 2027 Data Readout
Market Chameleon (Tue, 20-Oct 11:02 AM)
